Unistem Biosciences provides a full spectrum of stem cell therapy and umbilical cord banking services — research, experimental therapy and the collection, processing and cryopreservation of stem cells. Unistem is associated with Beike group, a leading biotechnology company specialising in treatment protocols using stem cells for varied ailments and injuries. The Beike technology has been utilised in nearly 20,000 stem cell transplants since 2001. Unistem backed by the expertise of Beike offers
stem cell therapy for patients with the following conditions:
Unistem works with various committees within the purview of the ICMR guidelines. These committees consist of medical professionals and scientists from major organisations. The doctors, scientists and stem cell experts at Unistem bring over 70 years of cumulative research experience, to treat patients with this cutting edge technology.